175 related articles for article (PubMed ID: 32641392)
21. Investigation of clinicopathological features of vulvar cancer in 1068 patients: A Japanese Gynecologic Oncology Group (JGOG) nationwide survey study.
Nishio S; Murotani K; Nakao S; Takenaka M; Suzuki S; Aoki Y; Todo Y; Hosaka M; Nakai H; Katabuchi H; Nishi H; Takekuma M; Mikami M; Enomoto T
Gynecol Oncol; 2020 Nov; 159(2):449-455. PubMed ID: 32854973
[TBL] [Abstract][Full Text] [Related]
22. Lymph node ratio has prognostic value related to the number of positive lymph nodes in patients with vulvar cancer.
Wu SG; Zhang WW; Li FY; Sun JY; Zhou J; He ZY
Future Oncol; 2018 Oct; 14(23):2343-2351. PubMed ID: 29807463
[TBL] [Abstract][Full Text] [Related]
23. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States.
Stroup AM; Harlan LC; Trimble EL
Gynecol Oncol; 2008 Mar; 108(3):577-83. PubMed ID: 18155274
[TBL] [Abstract][Full Text] [Related]
24. Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2.
Chokoeva AA; Tchernev G; Cardoso JC; Patterson JW; Dechev I; Valkanov S; Zanardelli M; Lotti T; Wollina U
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):178-86. PubMed ID: 25816393
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
[TBL] [Abstract][Full Text] [Related]
26. Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.
Xanthopoulos EP; Grover S; Puri PM; Corradetti MN; Heilbroner SP; Mitra N; Simone CB; Lin LL
Am J Clin Oncol; 2018 Sep; 41(9):845-850. PubMed ID: 30134287
[TBL] [Abstract][Full Text] [Related]
27. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
[TBL] [Abstract][Full Text] [Related]
28. Prognostic features of pediatric soft-tissue sarcomas.
Neifeld JP; Godwin D; Berg JW; Salzberg AM
Surgery; 1985 Jul; 98(1):93-7. PubMed ID: 4012611
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
[TBL] [Abstract][Full Text] [Related]
30. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time.
Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
Am J Obstet Gynecol; 2013 Nov; 209(5):468.e1-468.e10. PubMed ID: 23891626
[TBL] [Abstract][Full Text] [Related]
31. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
Köhler U; Schöne M; Pawlowitsch T
Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
[TBL] [Abstract][Full Text] [Related]
32. Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: a case report, review of the literature, and an argument for consolidation.
Argenta PA; Thomas S; Chura JC
Gynecol Oncol; 2007 Oct; 107(1):130-5. PubMed ID: 17692365
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer.
Zapardiel I; Gracia M; Díez J; Buda A; Noya MC; Iaco P; Vieira-Baptista P; Iacoponi S;
Arch Gynecol Obstet; 2021 Mar; 303(3):759-766. PubMed ID: 33067709
[TBL] [Abstract][Full Text] [Related]
34. External ear sarcoma: a review of the Surveillance Epidemiology and End Result (SEER 17) database.
Austin SA; Hawkshaw MJ; Sataloff RT
Ear Nose Throat J; 2011 Aug; 90(8):348-58. PubMed ID: 21853439
[TBL] [Abstract][Full Text] [Related]
35. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
36. National surgical patterns of care: regional lymphadenectomy of breast sarcomas.
Gullett NP; Delman K; Folpe AL; Johnstone PA
Am J Clin Oncol; 2007 Oct; 30(5):461-5. PubMed ID: 17921704
[TBL] [Abstract][Full Text] [Related]
37. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
38. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
39. Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival.
Bedi M; King DM; Charlson J; Whitfield R; Hackbarth DA; Zambrano EV; Wang D
Am J Clin Oncol; 2014 Jun; 37(3):272-7. PubMed ID: 23275272
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
